These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 6335925)
1. Treatment with high-dose oral vitamin D2 in patients with jejunoileal bypass for morbid obesity. Effects on calcium and magnesium metabolism, vitamin D metabolites, and faecal lag time. Charles P; Mosekilde L; Søndergård K; Jensen FT Scand J Gastroenterol; 1984 Nov; 19(8):1031-8. PubMed ID: 6335925 [TBL] [Abstract][Full Text] [Related]
2. Impairment of vitamin D metabolism and bone mineral content after intestinal bypass for obesity. A longitudinal study. Rickers H; Christiansen C; Balslev I; Rødbro P Scand J Gastroenterol; 1984 Mar; 19(2):184-9. PubMed ID: 6609420 [TBL] [Abstract][Full Text] [Related]
3. Symptomatic osteomalacia after jejunoileal bypass surgery in a patient with primary hyperparathyroidism. A study of the change in bone morphology and vitamin D metabolites before and during treatment. Taylor HC; Teitelbaum SL; Lambert PW Gastroenterology; 1983 Sep; 85(3):735-42. PubMed ID: 6603388 [TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of metabolic bone disease after jejunoileal bypass. Sellin JH; Meredith SC; Kelly S; Schneir H; Rosenberg IH Gastroenterology; 1984 Jul; 87(1):123-9. PubMed ID: 6724254 [TBL] [Abstract][Full Text] [Related]
5. [Calcium and bone metabolism after jejunal bypass operation for alimentary obesity: model for a intestinally-conditioned disorder (author's transl)]. Kruse HP; Kuhlencordt F; Montz R; Ringe JD; Koch G Dtsch Med Wochenschr; 1981 Sep; 106(38):1219-23. PubMed ID: 7343280 [TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
7. Vitamin D physiology. Lips P Prog Biophys Mol Biol; 2006 Sep; 92(1):4-8. PubMed ID: 16563471 [TBL] [Abstract][Full Text] [Related]
8. Role of vitamin D, its metabolites, and analogs in the management of osteoporosis. Bikle DD Rheum Dis Clin North Am; 1994 Aug; 20(3):759-75. PubMed ID: 7984788 [TBL] [Abstract][Full Text] [Related]
9. Serum concentration of vitamin D metabolites during treatment with vitamin D2 and D3 in normal premenopausal women. Tjellesen L; Hummer L; Christiansen C; Rødbro P Bone Miner; 1986 Oct; 1(5):407-13. PubMed ID: 2849489 [TBL] [Abstract][Full Text] [Related]
10. Low serum levels of 1.25-dihydroxyvitamin D and histomorphometric evidence of osteomalacia after jejunoileal bypass for obesity. Mosekilde L; Melsen F; Hessov I; Christensen MS; Lund BJ; Lund BI; Sørensen OH Gut; 1980 Jul; 21(7):624-31. PubMed ID: 7429327 [TBL] [Abstract][Full Text] [Related]
11. Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose. Klein RG; Arnaud SB; Gallagher JC; Deluca HF; Riggs BL J Clin Invest; 1977 Jul; 60(1):253-9. PubMed ID: 874087 [TBL] [Abstract][Full Text] [Related]
12. Bone histomorphometry and vitamin D status after biliopancreatic bypass for obesity. Compston JE; Vedi S; Gianetta E; Watson G; Civalleri D; Scopinaro N Gastroenterology; 1984 Aug; 87(2):350-6. PubMed ID: 6735078 [TBL] [Abstract][Full Text] [Related]
13. Vitamin D deficiency in obese patients and changes in circulating vitamin D metabolites following jejunoileal bypass. Hey H; Stokholm KH; Lund B; Lund B; Sørensen OH Int J Obes; 1982; 6(5):473-9. PubMed ID: 6983505 [TBL] [Abstract][Full Text] [Related]
14. Effect of 25-hydroxyvitamin D3 on vitamin D metabolites in primary biliary cirrhosis. Kaplan MM; Goldberg MJ; Matloff DS; Neer RM; Goodman DB Gastroenterology; 1981 Oct; 81(4):681-5. PubMed ID: 6973499 [TBL] [Abstract][Full Text] [Related]
15. Percent true calcium absorption, mineral metabolism, and bone mass in children with arthritis: effect of supplementation with vitamin D3 and calcium. Hillman LS; Cassidy JT; Chanetsa F; Hewett JE; Higgins BJ; Robertson JD Arthritis Rheum; 2008 Oct; 58(10):3255-63. PubMed ID: 18821668 [TBL] [Abstract][Full Text] [Related]
16. Effects of calcium, aluminium, magnesium and cholestyramine on hyperoxaluria in patients with jejunoileal bypass. Nordenvall B; Backman L; Larsson L; Tiselius HG Acta Chir Scand; 1983; 149(1):93-8. PubMed ID: 6837229 [TBL] [Abstract][Full Text] [Related]
17. Vitamin D metabolism and osteomalacia in cystic fibrosis. Friedman HZ; Langman CB; Favus MJ Gastroenterology; 1985 Mar; 88(3):808-13. PubMed ID: 3871414 [TBL] [Abstract][Full Text] [Related]
18. Treatment of osteomalacia in institutionalized epileptic patients on long-term anticonvulsant therapy. Hoikka V; Savolainen K; Karjalainen P; Alhava EM; Sivenius J Ann Clin Res; 1982 Apr; 14(2):72-5. PubMed ID: 6983324 [TBL] [Abstract][Full Text] [Related]
19. The osteodystrophy of hypervitaminosis D: a metabolic study. Davies M; Mawer EB; Freemont AJ Q J Med; 1986 Oct; 61(234):911-9. PubMed ID: 3498181 [TBL] [Abstract][Full Text] [Related]
20. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency. Leventis P; Kiely PD Scand J Rheumatol; 2009; 38(2):149-53. PubMed ID: 18991184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]